Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Ed Schwalbe

Newcastle AuthorsTitleYearFull text
- Lalchungnunga
Hande Atasoy
Dr Ed Schwalbe
Dr Christopher Bacon
Dr Gordon Strathdee
Deconvolution of haematological cancer methylation patterns reveals a predominantly non-disease related proliferation signal and uncovers true disease associated methylation changes2025
Dr Ed Schwalbe
Dr Janet Lindsey
Dr Marina Danilenko
Dr Rebecca Hill
Dr Stephen Crosier
et al.		Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort study2025
Dean Thompson
Dr Jemma Castle
Professor Simon Bailey
Dr Debbie Hicks
Professor Steven Clifford
et al.		Robust molecular subgrouping and reference-free aneuploidy detection in medulloblastoma using low-depth whole genome bisulfite sequencing2025
Dr Claire Keeling
Dr Jack Goddard
Dr Ed Schwalbe
Professor Simon Bailey
Dr Debbie Hicks
et al.		MDB-31. The clinical significance of sub-total surgical resection in childhood medulloblastoma: a multi-cohort analysis of 1100 patients.2024
Dr Marion Mateos
Dr Daniel Williamson
Dr Marina Danilenko
Dr Jack Goddard
Dr Stephen Crosier
et al.		MDB-64. Novel transcripts associate with survival in childhood medulloblastoma.2024
Dr Claire Keeling
Dr Jack Goddard
Dr Ed Schwalbe
Professor Simon Bailey
Dr Debbie Hicks
et al.		The clinical significance of sub-total surgical resection in childhood medulloblastoma: a multi-cohort analysis of 1100 patients2024
Dr Jack Goddard
Jemma Castle
Emily Southworth
Anya Fletcher
Dr Stephen Crosier
et al.		Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification2023
Wen Hao
Professor Deborah Tweddle
Dr Ed Schwalbe
Dr Gordon Strathdee
Genome wide DNA methylation analysis identifies novel molecular subgroups and predicts survival in neuroblastoma2022
Dr Jack Goddard
Dr Jemma Castle
Dr Stephen Crosier
Dr Daniel Williamson
Dr Ed Schwalbe
et al.		EMBR-25. Genome-wide genetic and epigenetic assessment of Group 4 medulloblastoma for improved, biomarker driven, prognostication and risk-stratification2021
Dr John Perry
Dr Ed Schwalbe
A chromatographic approach to distinguish Gram-positive from Gram-negative bacteria using exogenous volatile organic compound metabolites2017
Dr Ed Schwalbe
Dr Debbie Hicks
Professor Steven Clifford
Health-Related Quality of Life (HRQoL) in HIT-SIOP-PNET4 trial survivors: differences between medulloblastoma molecular subgroups2016
Dr Debbie Hicks
Dr Ed Schwalbe
Dr Stephen Crosier
Professor Simon Bailey
Dr Daniel Williamson
et al.		Identification of medulloblastoma molecular subgroups using metabolite profiles2016
Dr Janet Lindsey
Dr Rebecca Hill
Dr Ed Schwalbe
Dr Christopher Howell
Dr Reza Rafiee
et al.		Molecular and Prognostic Heterogeneity within MYC and MYCN Amplified Medulloblastomas2016
Dr Ed Schwalbe
Dr Debbie Hicks
Dr Reza Rafiee
Dr Matthew Bashton
Dr Amir Enshaei
et al.		Routine Diagnostic Medulloblastoma Subgrouping Using Low-Cost, Low-Input DNA Methylomics: Application to Trials Cohorts Previously Refractory-to-Analysis2016
Dr Ed Schwalbe
Dr Debbie Hicks
Dr Reza Rafiee
Dr Matthew Bashton
Dr Amir Enshaei
et al.		Routine molecular subgrouping of medulloblastoma: Bridging the divide between research and the clinic using low-cost, mass spectrometry-based DNA methylomics2016
123